Powder Pharms

Powder Pharmaceuticals, Inc. (PPI), often identified in regulatory filings as Powder Pharms, is a specialty pharmaceutical and medical device company headquartered in Hong Kong. The company focuses on the development and commercialization of needle-free intradermal drug delivery systems, utilizing a proprietary technology platform originally acquired from the legacy of PowderJect. Its flagship product, Zingo (lidocaine hydrochloride monohydrate), is an FDA-approved needle-free powder injection system that provides rapid local analgesia for patients undergoing peripheral IV placements or blood draws. Beyond its commercial pain management offerings, the company is leveraging its delivery platform to develop a pipeline of products, including a continuous blood glucose monitoring system in collaboration with EyeSense AG.